脑膜炎球菌监测澳大利亚:报告期为2023年7月1日至9月30日
Monica M Lahra1,2, Tiffany R Hogan1
1World Health Organization Collaborating Centre for STI and AMR, Sydney; Neisseria Reference Laboratory, New South Wales Health Pathology, Microbiology, The Prince of Wales Hospital, Randwick, NSW 2031, Australia.
Communicable diseases intelligence (2018)
|June 27, 2024
概括
澳大利亚脑膜炎球菌监测计划 (AMSP) 追踪侵入性脑膜炎球菌病 (IMD) 病例. 实验室数据提供季度更新的IMD病例数,按地区和血清组划分.
科学领域:
- 公共卫生 微生物学
- 流行病学 流行病学
- 传染病监测 传染病监测 传染病
背景情况:
- 侵入性脑膜炎球菌病 (IMD) 在全球范围内仍然是一个重大的公共卫生问题.
- 有效的监测对于了解疾病负担和指导控制策略至关重要.
- 澳大利亚脑膜炎球菌监测计划 (AMSP) 在监测澳大利亚IMD方面发挥着至关重要的作用.
研究的目的:
- 报告澳大利亚实验室确认的侵袭性脑膜炎球菌病 (IMD) 病例数.
- 按司法管辖区和血清组提供IMD发病率的及时数据.
- 作为AMSP综合年度报告的基础.
主要方法:
- 使用培养和基于分子的技术,实验室确认IMD病例.
- 由AMSP参考实验室收集和报告数据.
- 按地理司法管辖区和内炎菌血清组对病例的分类.
主要成果:
- 每季度的报告详细说明了确诊的IMD病例的数量.
- 数据按澳大利亚州和领地分层.
- 如果有,则提供血清组信息.
结论:
- 每季度的AMSP报告提供了重要的,最新的IMD监测数据.
- 这些数据支持正在进行的公共卫生干预和研究.
- 年度报告提供了对IMD趋势的更深入分析.
相关概念视频
Pharmacovigilance
2.0K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
2.0K
Principles of Disease Surveillance
853
Disease surveillance is the systematic collection, analysis, and interpretation of health data essential to the planning, implementation, and evaluation of public health practice. This process integrates data dissemination to entities responsible for preventing and controlling disease, injury, and disability. Surveillance systems provide crucial information for action, helping public health authorities make informed decisions to manage and prevent outbreaks, ensure public safety, optimize...
853
Infectious Diseases and Their Occurrence
94
Infectious diseases appear in populations through various transmission patterns, influenced by pathogen characteristics, population immunity, environmental conditions, and social behavior. Understanding these patterns is essential for effective public health surveillance and intervention. These categories—sporadic, outbreak, epidemic, pandemic, and endemic—help frame the nature and scope of disease events.Sporadic diseases occur irregularly and infrequently, without a predictable...
94
Viral Meningitis
199
Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
199
Bacterial Meningitis I: Introduction
15
Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
15
Bacterial Meningitis II: Pathophysiology
24
Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
24


